Breast Milk Enhances Growth of Enteroids: An Ex Vivo Model of Cell Proliferation
February 15th, 2018
18.9K views
This protocol describes how to establish an enteroid culture system from neonatal mouse or premature human intestine as well as an efficient method to collect milk from mice.
Overview
This protocol describes the establishment of an enteroid culture system from neonatal mouse or premature human intestine and an efficient method to collect milk from mice. Enteroids are cultured to study the effects of breast milk on intestinal proliferation in vitro.
Key Study Components
Area of Science
- Neuroscience
- Gastroenterology
- Cell Culture
Background
- Enteroids are miniature gut models that mimic the human small intestine.
- This method can provide insights into gastrointestinal diseases like necrotizing enterocolitis.
- Enteroids require minimal maintenance and can be established quickly.
- The technique can be applied to other organ systems in the gastrointestinal tract.
Purpose of Study
- To culture enteroids for studying the effects of breast milk on intestinal cells.
- To investigate key questions related to gastrointestinal diseases.
- To develop a reliable in vitro model for research.
Methods Used
- Establishment of enteroid cultures from neonatal mouse or human intestine.
- Extraction of mouse breast milk for treatment of enteroids.
- In vitro analysis of cell proliferation.
- Assessment of functional properties of enteroids.
Main Results
- Enteroids exhibit many functional properties of the gastrointestinal epithelium.
- The method allows for rapid establishment and maintenance of cultures.
- Insights gained can inform research on gastrointestinal diseases.
- Potential applications extend beyond the small intestine to other GI tract regions.
Conclusions
- The enteroid culture system is a valuable tool for studying intestinal biology.
- This method can enhance understanding of the effects of breast milk on gut health.
- Future research can leverage this technique for various gastrointestinal conditions.
Frequently Asked Questions
What are enteroids?
Enteroids are miniature gut models that replicate the structure and function of the human small intestine.
Why is breast milk important in this study?
Breast milk contains factors that may influence intestinal cell proliferation and health, making it crucial for understanding gut development.
How are enteroids maintained in the lab?
Enteroids require minimal maintenance and can be cultured with specific growth factors and nutrients.
What diseases can this model help study?
This model can provide insights into various gastrointestinal diseases, including necrotizing enterocolitis.
Can this method be applied to other organ systems?
Yes, while primarily focused on the small intestine, the technique can be adapted for other regions of the gastrointestinal tract.
Executive Industry Relevance
This protocol establishes a physiologically relevant ex vivo model for evaluating bioactive compounds in intestinal epithelial systems, supporting early-stage target validation in gastroenterology and nutrition research. By demonstrating species-specific effects of breast milk on enteroid proliferation, the method provides quantitative, reproducible readouts that enable mechanistic de-risking of nutraceutical or therapeutic candidates targeting gut barrier function and mucosal repair. The platform supports translational continuity from discovery to preclinical assessment by modeling human intestinal responses in a scalable, bankable format.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of breast milk-derived factors on intestinal stem cell proliferation and epithelial differentiation.
- Operational Value: Provides a standardized, serum-free culture system for consistent compound testing across laboratories.
Screening & Assay Development
- Scientific Value: Generates quantifiable proliferation metrics via immunofluorescence staining for high-content screening applications.
- Operational Value: Supports assay standardization through defined crypt isolation, embedding, and growth factor supplementation steps.
Translational & Preclinical Research
- Scientific Value: Models species-specific intestinal responses to nutritional factors, relevant for infant formula and preterm nutrition development.
- Operational Value: Allows banking of enteroid lines for longitudinal studies and cross-laboratory reproducibility.
Pipeline & Workflow Integration
The method fits within the discovery biology workflow, enabling hypothesis testing of luminal factors on epithelial homeostasis prior to lead identification in gastroenterology or maternal-child health programs.
- Discovery Biology: Supports mechanistic interrogation of breast milk components on Wnt, Notch, or EGFR signaling pathways in intestinal crypts.
- Screening: Delivers fluorescence-based proliferation readouts compatible with automated imaging and image analysis pipelines.
- Analytics: Enables quantification of EdU+ or Ki67+ cells as dependent variables for dose-response modeling.
- Translational Research: Connects to preterm infant health models by using premature human intestinal tissue and donor milk simulations.
- Enterprise Reuse: Establishes a reusable platform for testing microbiota, immune cells, or drug candidates in a defined epithelial microenvironment.
Operational & Enterprise Impact
- Scientific Value: Reduces mechanistic ambiguity in nutraceutical mode-of-action studies through direct epithelial readouts.
- Operational Value: Enables rapid establishment and low-maintenance culture, increasing throughput for screening campaigns.
- Strategic Value: Improves go/no-go decisions by providing human-relevant proliferation data early in discovery.
- Portfolio Impact: Supports risk-adjusted prioritization of breast milk-derived biologics or synthetic analogs for neonatal gut health.
Implementation Considerations
- Requires expertise in murine surgery, tissue dissection, and sterile crypt isolation techniques.
- Dependent on access to lactating animal models and breast milk expression equipment (e.g., adapted breast pump).
- Necessitates standardized basement membrane preparation and polymerization to ensure consistent enteroid formation.
- Requires optimization of growth factor concentrations when adapting to human premature intestinal crypts.
- Limited by availability of premature human tissue and ethical considerations in maternal-infant research models.
Biopharma FAQs
Why is proliferation quantification important for target validation in gut models?
Quantifying proliferation via immunofluorescence (e.g., EdU or Ki67 staining) provides a measurable dependent variable to assess the biological activity of breast milk on intestinal stem cells, enabling objective comparison across treatment conditions and supporting hypothesis-driven target validation.
How does isolating intestinal crypts enable independent variable control in enteroid experiments?
Isolating intestinal crypts ensures a defined starting population of stem and progenitor cells, allowing researchers to treat enteroids with specific breast milk samples as the independent variable while minimizing variability from differentiated cell contamination or uneven tissue input.
What quantitative measurements enable assessment of breast milk effects on enteroid growth?
Immunofluorescence staining for proliferation markers (e.g., EdU incorporation or Ki67 expression) combined with imaging and image analysis yields quantitative readouts of cell division rates, enabling statistical comparison between mouse, human, and donor breast milk treatments.
Why are replication requirements critical for cross-functional collaboration in enteroid studies?
Replicating enteroid isolation, embedding, and treatment across multiple wells and experiments ensures data reproducibility, which is essential for aligning discovery biology, assay development, and preclinical teams on consistent, translatable results.
What statistical analysis capabilities are required before implementing breast milk treatment studies in enteroid models?
Implementing these studies requires capability for quantitative image analysis, normalization of fluorescence intensity, and application of statistical tests (e.g., t-test or ANOVA) to determine significant differences in proliferation rates across experimental groups.
